In parallel, SETD8-mediated mono-methylation of p53 at lysine 382, induced by tumor-associated macrophages through IL-6/MCP-1 signaling, functionally inactivates p53 in CRC stem cells, facilitating immune evasion and tumor progression [71]. The gene discussed is TP53; the disease is colorectal carcinoma.